Australians Living with and Managing Hepatitis C

REFERENCES

• Aitken, C. K., Lewis, J., Tracy, S. L., Spelman, D. S., Bharadwaj, M., Drummer, H., & Hellard, M. (2008). High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology, 48(6), 1746–1752.
   PubMedGoogle Scholar
• Baker, A., Bucci, S., Lewin, T. J., Kay-Lambkin, F., Constable, P. M., & Carr, V. J. (2006). Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders. British Journal of Psychiatry, 188, 439–448.
   PubMed Web of Science ®Google Scholar
• Baker, A., Lee, N. K., Claire, M., Lewin, T. J., Grant, T., Pohlman, S., Saunders, J. B., Kay-Lambkin, F., Constable, P., Jenner, L., & Carr, V. J. (2005). Brief cognitive-behavioural interventions for regular amphetamine users: A step in the right direction. Addiction, 100, 367–378.
   PubMed Web of Science ®Google Scholar
• Butler, A. C., Chapman, J. E., Forman, E. M., & Beck, A. T. (2006). The empirical status of cognitive-behavioural therapy: A review of meta-analyses. Clinical Psychology Review, 26, 17–31.
   PubMed Web of Science ®Google Scholar
• Commonwealth of Australia. (2005). National Hepatitis C Strategy 2005–2008, Canberra: Australian Government Office. Available: http://www.health.vic.gov.au/hivaids/hepatitisc.pdf
   Google Scholar
• Copeland, J., Swift, W., Roffman, R., & Stephens, R. (2001). A randomized controlled trial of brief cognitive-behavioural interventions for cannabis use disorder. Journal of Substance Abuse Treatment, 21(2), 55–64.
   PubMed Web of Science ®Google Scholar
• Crockett, B., & Gifford, S. M. (2004). Eyes wide shut: Narratives of women living with hepatitis C in Australia. Women & Health 39(4), 117–137.
   PubMed Web of Science ®Google Scholar
• Day, C., Ross, J., & Dolan, K. (2003). Hepatitis C-related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination? Drug & Alcohol Review, 22(3), 317–321.
   PubMed Web of Science ®Google Scholar
• Gifford, S. M., O’Brien, M. L., Bammer, G., Banwell, C., & Stoove, M. (2003). Australian women's experiences of living with hepatitis C virus: Results from a cross-sectional survey. Journal of Gastroenterology & Hepatology, 18(7), 841–850.
   PubMed Web of Science ®Google Scholar
• Gifford, S. M., O’Brien, M. L., Smith, A., Templesmith, M., Stoove, M., Mitchell, D., & Jolley, D. (2005). Australian men's experiences of living with hepatitis C virus: Results from a cross-sectional survey. Journal of Gastroenterology & Hepatology, 20(1), 79–86.
   PubMedGoogle Scholar
• Gluud, L., & Gluud, C. (2009). Meta-analyses on Viral Hepatitis. Infectious disease clinics of North America, 23(2), 315–330.
   PubMedGoogle Scholar
• Goldberg, R. W., & Seth, P. (2008). Hepatitis C services and individuals with serious mental illness. Community Mental Health Journal, 44, 381–384.
   PubMedGoogle Scholar
• Golden, J., O’Dwyer, A. M., & Conroy, R. M. (2005). Depression and anxiety in patients with hepatitis C: Prevalence, detection rates and risk factors. General Hospital Psychiatry, 27(6), 431–438.
   PubMed Web of Science ®Google Scholar
• Haley, R. W., & Fischer, R. P. (2001). Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine, 80(2), 134–151.
   PubMedGoogle Scholar
• Hellard, M. E., & Wang. Y. H. (2009). The role of general practitioners in managing and treating hepatitis C. Medical Journal of Australia, 191(10), 523–524.
   PubMedGoogle Scholar
• Hepatitis C Virus Projections Working Group. (2006). Estimates and projections of the Hepatitis C virus epidemic in Australia 2006. Sydney: NCHECR, UNSW. Available: http://www.health.gov.au/internet/main/publishing.nsf/Content/phd-hepc-estimates-project-06
   Google Scholar
• Hopwood, M., & Treloar, C. (2003). The 3D Project: Diagnosis, disclosure, discrimination and living with Hepatitis C. Sydney: National Centre in HIV Social Research.
   Google Scholar
• Klinkenberg, W. D., Caslyn, J., Morse, G. A., Yonker, R. D., McCudden, S., Ketema, F., & Constantine, N. T. (2003). Prevalence of human immunodeficiency virus, Hepatitis B, and Hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Comprehensive Psychiatry, 44(4), 293–302.
   PubMed Web of Science ®Google Scholar
• Kwon, J. A., Iversen, J., Maher, L., Law, M. G., & Wilson, D. P. (2009). The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: A model-based analysis. Journal of Acquired Immune Deficiency Syndrome, 51(4), 462–469.
   PubMedGoogle Scholar
• Loughlin, A. M., Schwartz, R., & Strathdee, S. A. (2004). Prevalence and correlates of HCV infection among methadone maintenance attendees: Implications for HCV treatment. International Journal of Drug Policy, 15, 93–101.
   Google Scholar
• McDermut, W., Miller, I. W., & Brown, R. A. (2001). The efficacy of group psychotherapy for depression: A meta-analysis and review of the empirical research. Clinical Psychology: Science and Practice, 8(1), 98–116.
   Web of Science ®Google Scholar
• McGovern, B., Birch, C., Bowen, M. J., Reyor, L. L., Nagami, E. H., Chung, R. T., & Kim, A. Y. (2009). Improving the diagnosis of acute Hepatitis C virus infection with expanded viral load criteria. Clinical Infectious Diseases, 49(7), 1051–1060.
   PubMed Web of Science ®Google Scholar
• McMahon, J. M., Pouget, E. R., & Tortu, S. (2007). Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: A multilevel dyadic analysis. Journal of Infectious Diseases, 195(11), 1572–1581.
   PubMedGoogle Scholar
• National Centre in HIV Epidemiology and Clinical Research. (2009). Australian NSP Survey National Data Report 2004–2008. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales.
   Google Scholar
• Oei, T. P., & Dingle, G. (2008). The effectiveness of group cognitive behaviour therapy for unipolar depressive disorders. Journal of Affective Disorders, 107(1–3), 5–21.
   PubMed Web of Science ®Google Scholar
• Olsen, A., Banwell, C., & Dance, P. (2009). Internal or infernal devices: Experiences of contraception among Australian women living with Hepatitis C. Health Care for Women International, 30(6), 456–474.
   PubMed Web of Science ®Google Scholar
• Orr, N., & Leeder, S. (1997). The public health challenge of hepatitis C. Australian & New Zealand Journal of Public Health, 22(2), 191–195.
   Google Scholar
• Petronio, S., Ellemers, N., Giles, H., & Gallois, C. (1998). (Mis)communicating across boundaries: Interpersonal and intergroup considerations. Communication Research, 25(6), 571–595.
   Web of Science ®Google Scholar
• Pugh, J. (2008). Hepatitis C and the Australian news media: A case of “bad blood.” Continuum: Journal of Media & Cultural Studies, 22(3), 385–394.
   Web of Science ®Google Scholar
• Rowe, W., Rowe, J., & Malowaniec, L. (2000). Hepatitis C: Mental health issues. Canadian Journal of Public Health, 91, S42.
   Google Scholar
• Seccull, A., Richmond, J., Thomas, B., & Herrman, H. (2006). Hepatitis C in people with mental illness: How big is the problem and how do we respond? Royal Australian and New Zealand College of Psychiatrists, 14(4), 374–378.
   PubMedGoogle Scholar
• Shand, F., Gates, J., Fawcett, J., & Mattick, R. (2003). The treatment of alcohol problems: A review of the evidence. Sydney: National Alcohol Strategy, National Drug and Alcohol Research Centre. Retrieved November 17, 2009, from http://www.alcohol.gov.au/internet/alcohol/publishing.nsf/Content/AAG08
   Google Scholar
• Stringari-Murray, S., Clayton, A., & Chang, J. (2003). A model for integrating hepatitis C services into an HIV/AIDS Program. Journal of the Association of Nurses in AIDS Care, 14(5), 95S–107S.
   Google Scholar
• Sylvestre, D. L., & Zweben, J. E. (2007). Integrating HCV services for drug users: A model to improve engagement and outcomes. International Journal of Drug Policy, 18, 406–410.
   PubMed Web of Science ®Google Scholar
• Wand, H., Spiegelman, D., Law, M., Jalaludin, B., Kaldor, J., & Maher, L. (2009). Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: Implications for prevention policy and planning. Addiction, 104, 2049–2056.
   PubMed Web of Science ®Google Scholar
• Westen, D., & Morrison, K. (2001). A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: An empirical examination of the status of empirically supported therapies. Journal of Consulting and Clinical Psychology, 69, 875–900.
   PubMed Web of Science ®Google Scholar
• Wright, J. H., & Beck, A. T. (1983). Cognitive therapy of depression: Theory and practice. Hospital and Community Psychiatry, 34(12), 1119–1127.
   PubMedGoogle Scholar